Feedback to MHRA / British Pharmacopoeia: Guidance on the application of vector copy number for the cell and gene therapy community
High Level Analytics members participated in a series of meetings to review British Pharmacopoeia: Guidance on the application of vector copy number for the cell and gene therapy community which was published for public consultation July 2021.
A summary document detailing consolidated feedback and suggested recommendations that represented the views of member companies was submitted to the MHRA in October 2021
I don't have access to this document
Make a selection below and submit your request. We will get back to you ASAP.
My company would like to become a member
If you're not sure if your company is a member of this Phorum, or if you would like to enquire on behalf of your company about becoming a member, please see our membership page.